These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 27756125)

  • 21. Identification and characterization of beta-lactamase inhibitor protein-II (BLIP-II) interactions with beta-lactamases using phage display.
    Brown NG; Palzkill T
    Protein Eng Des Sel; 2010 Jun; 23(6):469-78. PubMed ID: 20308189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insights into positive and negative requirements for protein-protein interactions by crystallographic analysis of the beta-lactamase inhibitory proteins BLIP, BLIP-I, and BLP.
    Gretes M; Lim DC; de Castro L; Jensen SE; Kang SG; Lee KJ; Strynadka NC
    J Mol Biol; 2009 Jun; 389(2):289-305. PubMed ID: 19332077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Next-Generation β-Lactamase Inhibitor Taniborbactam Restores the Morphological Effects of Cefepime in KPC-Producing Escherichia coli.
    Roach EJ; Uehara T; Daigle DM; Six DA; Khursigara CM
    Microbiol Spectr; 2021 Oct; 9(2):e0091821. PubMed ID: 34494877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loop.
    Winkler ML; Papp-Wallace KM; Bonomo RA
    J Antimicrob Chemother; 2015 Aug; 70(8):2279-86. PubMed ID: 25957381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of residues in beta-lactamase critical for binding beta-lactamase inhibitory protein.
    Rudgers GW; Palzkill T
    J Biol Chem; 1999 Mar; 274(11):6963-71. PubMed ID: 10066750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the binding forces driving the tight interactions between beta-lactamase inhibitory protein-II (BLIP-II) and class A beta-lactamases.
    Brown NG; Chow DC; Sankaran B; Zwart P; Prasad BV; Palzkill T
    J Biol Chem; 2011 Sep; 286(37):32723-35. PubMed ID: 21775426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel non-β-lactam inhibitor of β-lactamase TEM-171 based on acylated phenoxyaniline.
    Grigorenko VG; Andreeva IP; Rubtsova MY; Deygen IM; Antipin RL; Majouga AG; Egorov AM; Beshnova DA; Kallio J; Hackenberg C; Lamzin VS
    Biochimie; 2017 Jan; 132():45-53. PubMed ID: 27771370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Display of functional beta-lactamase inhibitory protein on the surface of M13 bacteriophage.
    Huang W; Petrosino J; Palzkill T
    Antimicrob Agents Chemother; 1998 Nov; 42(11):2893-7. PubMed ID: 9797222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deep Sequencing of a Systematic Peptide Library Reveals Conformationally-Constrained Protein Interface Peptides that Disrupt a Protein-Protein Interaction.
    Boragine DM; Huang W; Su LH; Palzkill T
    Chembiochem; 2022 Feb; 23(3):e202100504. PubMed ID: 34821011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-based approach for identification of novel phenylboronic acids as serine-β-lactamase inhibitors.
    Sgrignani J; De Luca F; Torosyan H; Docquier JD; Duan D; Novati B; Prati F; Colombo G; Grazioso G
    J Comput Aided Mol Des; 2016 Oct; 30(10):851-861. PubMed ID: 27632226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A beta-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France.
    Petrella S; Ziental-Gelus N; Mayer C; Renard M; Jarlier V; Sougakoff W
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3725-36. PubMed ID: 18625772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding the molecular determinants of substrate and inhibitor specificities in the Carbapenemase KPC-2: exploring the roles of Arg220 and Glu276.
    Papp-Wallace KM; Taracila MA; Smith KM; Xu Y; Bonomo RA
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4428-38. PubMed ID: 22687511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 4-Alkyl-1,2,4-triazole-3-thione analogues as metallo-β-lactamase inhibitors.
    Gavara L; Legru A; Verdirosa F; Sevaille L; Nauton L; Corsica G; Mercuri PS; Sannio F; Feller G; Coulon R; De Luca F; Cerboni G; Tanfoni S; Chelini G; Galleni M; Docquier JD; Hernandez JF
    Bioorg Chem; 2021 Aug; 113():105024. PubMed ID: 34116340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Azetidinimines as a novel series of non-covalent broad-spectrum inhibitors of β-lactamases with submicromolar activities against carbapenemases KPC-2 (class A), NDM-1 (class B) and OXA-48 (class D).
    Romero E; Oueslati S; Benchekroun M; D'Hollander ACA; Ventre S; Vijayakumar K; Minard C; Exilie C; Tlili L; Retailleau P; Zavala A; Elisée E; Selwa E; Nguyen LA; Pruvost A; Naas T; Iorga BI; Dodd RH; Cariou K
    Eur J Med Chem; 2021 Jul; 219():113418. PubMed ID: 33862516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The presence of extended spectrum beta-lactamase, KPC-type carbapenemase and plasmid-mediated AmpC beta-lactamase in E.coli and K.pneumoniae strains isolated from blood cultures].
    Baykal A; Cöplü N; Simşek H; Esen B; Gür D
    Mikrobiyol Bul; 2012 Apr; 46(2):159-69. PubMed ID: 22639305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance to beta-lactamase inhibitor protein does not parallel resistance to clavulanic acid in TEM beta-lactamase mutants.
    Schroeder WA; Locke TR; Jensen SE
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3568-73. PubMed ID: 12384366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BLIP-II is a highly potent inhibitor of Klebsiella pneumoniae carbapenemase (KPC-2).
    Brown NG; Chow DC; Palzkill T
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3398-401. PubMed ID: 23587951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elucidating the role of Trp105 in the KPC-2 β-lactamase.
    Papp-Wallace KM; Taracila M; Wallace CJ; Hujer KM; Bethel CR; Hornick JM; Bonomo RA
    Protein Sci; 2010 Sep; 19(9):1714-27. PubMed ID: 20662006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancing the activity of β-lactamase inhibitory protein-II with cell-penetrating peptide against KPC-2-carrying Klebsiella pneumoniae.
    Chatupheeraphat C; Peamchai J; Kaewsai N; Anuwongcharoen N; Eiamphungporn W
    PLoS One; 2024; 19(1):e0296727. PubMed ID: 38277388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical Activity of Vaborbactam.
    Tsivkovski R; Lomovskaya O
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.